• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

2017 TVM Capital Life Science Autumn Conference

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

autumn-conference-2017

Thank You!

Now in its 6th year, our annual TVM Capital Life Science Autumn Conference 2017 was held on Monday, September 18th in Montreal.

This year, our invitation-only conference was attended by 200 international participants from Asia, the United States and Europe who joined us to network with senior decision makers from biotech and pharmaceutical companies as well as venture capital groups to discuss latest trends in our industry as well as share expertiese and experience.  We thank all attendants, speakers and the sponsors of  our conference for lively discussions and interesting insights. Please see our news release to learn more.

Agenda

11.30amRegistration and light lunch
12.30pmWelcome Address
Hubert Birner, Managing Partner, TVM Capital Life Science
12.45pmKeynote Speaker
Marc de Garidel – Chairman, IPSEN
Introduction: Vanessa Grant, Norton Rose Fulbright
13.30pmKeynote Speaker
Andrew Dahlem, Vice President, COO, Lilly Research Laboratories/LRL Europe
Introduction: Daniel Parera, Executive-in-Residence, TVM Capital Life Science
2.15pmPanel Discussion: New Models in Venture Capital
Moderator: Luc Marengere, Managing Partner, TVM Capital Life Science

Panellists:
Peter van der Velden – Managing General Partner, Lumira Capital
Jean-Francois Leprince – Managing Partner, CtI Life Sciences
Barbara Dalton – Vice President Venture Capital, Pfizer
Didier Leconte – Senior Investment Director, Fonds de solidarité FTQ
David Hirsch - Managing Director and Founder, Longitude Capital
3.00pmNew members of the TVM Capital Life Science Portfolio – An Introduction
Arndt Rolfs – CEO and founder, Centogene, Berlin
Gabriel Robichaud – President and co-founder, Panthera Dental, Quebec City
3.45pmCoffee Break
4.15pmPanel Discussion: Orphan Drugs & Rare Diseases
Moderator: Marc Rivière, General Partner, TVM Capital Life Science

Panellists:
Clarissa Desjardins – CEO, Clementia Pharmaceuticals
Angela Genge – Medical Director, Clinical Research Unit and ALS Clinic, Neurological Institute and Hospital
Robert Steiner - Chief Medical Officer, Acer Therapeutics
Stacy Coen - Head of Rare Disease Business Development and Licensing, Sanofi
5.00pm“A Macro Economic View”
Nils Behnke - Director, Bain & Company
Introduction: Hubert Birner, Managing Partner, TVM Capital Life Science
5.45pmWrap up and Outlook
Luc Marengere, Managing Partner, TVM Capital Life Science
6.00pmNetworking Reception: Salon Paloma Picasso

Download Agenda (PDF)

Platinum Sponsor
norton-rose-fulbright
Gold Sponsors
aird & berlis Banque Nationale clark-elbingErnst & Young foley hoag fondsftq RBC

2017 TVM Capital Life Science Autumn Conference

Date:
September 18 2017
Venue:
Montreal

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact